About InnoGenomics
InnoGenomics is a company based in New Orleans (United States) founded in 2010.. InnoGenomics offers products and services including InnoTyper® 21, InnoQuant® HY, SpermX™, Mock Forensic Samples, and Custom Services. InnoGenomics operates in a competitive market with competitors including DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others.
- Headquarter New Orleans, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Innogenomics Technologies, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$350.64 K (USD), Grant
Jan 01, 2018
-
Investors
Ojp
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InnoGenomics
InnoGenomics offers a comprehensive portfolio of products and services, including InnoTyper® 21, InnoQuant® HY, SpermX™, Mock Forensic Samples, and Custom Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for forensic DNA analysis in challenging samples.
Assesses human and male DNA quantity and quality.
Captures sperm cells for forensic DNA processing.
Simulates forensic scenarios for lab testing.
Provides custom biological samples and analysis.
Unlock access to complete
Unlock access to complete
Funding Insights of InnoGenomics
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $350,641
-
First Round
First Round
(26 May 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Grant - InnoGenomics | Valuation |
investors |
|
| Jun, 2016 | Amount | Grant - InnoGenomics | Valuation |
investors |
|
| Aug, 2012 | Amount | Grant - InnoGenomics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InnoGenomics
InnoGenomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Ojp and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Federal justice system funding, training, and resources are provided.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InnoGenomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InnoGenomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Innogenomics Comparisons
Competitors of InnoGenomics
InnoGenomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, NeuMoDx, Biocartis, Biomeme and Molbio Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Molecular assays for disease detection are developed using proprietary technology.
|
|
| domain | founded_year | HQ Location |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Instruments for rapid human DNA identification are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about InnoGenomics
When was InnoGenomics founded?
InnoGenomics was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is InnoGenomics located?
InnoGenomics is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
What does InnoGenomics do?
InnoGenomics Technologies is a biotechnology company engaged in the development of next-generation genetic markers and test kits. The company has invented a mini-primer design that has allowed usage of Retrotransposable Elements (REs) as informative biomarkers. It has developed RE-based PCR and Real-Time qPCR assays which can be used in various fields including forensic and missing person identification, relationship and ancestral ethno-geographic establishment, and molecular diagnostics. As of September 23, 2016, the company offers 4 products: InnoQuant Kit- for checking quality, integrity and quantification of human DNA; INNOTYPER 21- a small amplicon (60-125 bp) DNA typing system; INNOQUANT HY- test for measuring quality, quantity and integrity of human male DNA and realistic mock samples for simulating forensic situations. The company is also developing a liquid biopsy method based on their InnoQuant kit technology for cancer detection and monitoring. The cancer detection device is supported by the U.S. National Cancer Institute (NCI).
Who are the top competitors of InnoGenomics?
InnoGenomics's top competitors include DermTech, Biocartis and Molbio Diagnostics.
What products or services does InnoGenomics offer?
InnoGenomics offers InnoTyper® 21, InnoQuant® HY, SpermX™, Mock Forensic Samples, and Custom Services.
Who are InnoGenomics's investors?
InnoGenomics has 2 investors. Key investors include Ojp, and National Science Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.